Mediphar Invest SA
Mediphar Invest reported total assets of 61,984 € at the end of the 2026 financial year (annual accounts filed with the NBB on 29 Sep 2026).
The score of Mediphar Invest shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Equity -53 % Total assets 0 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Mediphar Invest's annual accounts
Filed annual accounts
- Year ended 31 Mar 2026filed on 29 Sep 2026
- Year ended 31 Mar 2025filed on 13 Oct 2025
- Year ended 31 Mar 2024filed on 17 Oct 2024
- Year ended 31 Mar 2023filed on 15 Sep 2023
- Year ended 31 Mar 2022filed on 08 Aug 2023
Mediphar Invest's financial analysis
- Solvency23.2%sector median: 55.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Mediphar Invest
Mediphar Invest's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0449.618.853
- VAT number
- BE0449618853
- Peppol
- Registered · 0208:0449618853 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 09 Mar 1993
- Registered office
- 2440 Geel
- Latest accounts
- 2026 · filed on 29 Sep 2026
- Activity
- Other information service activities (NACE 63920)
Mediphar Invest (SA) has been based in Geel since 1993, active in: other information service activities. For 2026, it reports a net loss of 3,787 € and equity of 14,368 €; its revenue is not published. Its solvency stands at 23.2%, below the median of its sector (55.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Mediphar Invest
Companies in the same business, of comparable size and area, outside its group.
- T-RES Infi Dour · balance sheet 61,993 €
- NTH Inficare Nursing and midwifery activities Ninove · balance sheet 61,998 €
- SPV Diksmuidestraat Buying and selling of own real estate Kortrijk · balance sheet 62,000 €
- Alma Lokeren Rental and operating of own or leased real estate Lokeren · balance sheet 61,962 €
Frequently asked questions about Mediphar Invest
What is the revenue of Mediphar Invest?
Mediphar Invest files its accounts in a format where revenue is optional: it is not published for 2026.
What is the VAT number of Mediphar Invest?
In Belgium, the VAT number is the company number prefixed with BE: BE0449618853 for Mediphar Invest, if the company is VAT-registered. Its company number (CBE) is 0449.618.853.
Where is the registered office of Mediphar Invest?
According to the CBE register, the registered office of Mediphar Invest is in 2440 Geel.
What is the equity of Mediphar Invest?
At the close of the 2026 financial year, the equity of Mediphar Invest amounts to 14,368 €, a solvency of 23.2% of total assets.
Who manages Mediphar Invest?
The register lists 3 active mandates at Mediphar Invest. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Mediphar Invest
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →